European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant fusion protein consisting of human coagulation f
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant fusion protein consisting of human coagulation factor VIII attached to the Fc domain of human IgG1
| EU orphan designation number: | EU/3/10/783
|
| Active ingredient: | Recombinant fusion protein consisting of human coagulation factor VIII attached to the Fc domain of human IgG1 |
| Indication: | Treatment of haemophilia A |
| Sponsor: | Biogen Idec Limited
Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 22/09/2010 | Centralised Orphan - Designation | EMA/OD/030/10 | (2010)6650 of 20/09/2010 |